NMSIS SITE INDEX
WELCOME
About Us
NMSIS Services
What is NMSIS?
Contact Us
NMSIS Office
Professional Advisory Council
& International Partners
Latest News
Newsletter
Call For Papers
Education
Publications
Articles & Books
Brochures
References
Medical Education Programs
NMS Program
Serotonin Syndrome
Promising New Investigators Travel Scholarship
Learn More
Winners Announced
Call For Papers
Quotes from Awardees
In-Service Training
Hotline Case Challenge
Speakers Bureau
What Is NMS?
Diagnostic Criteria
What Drugs Are Associated with NMS?
Nurses Corner
coming soon
Articles & Books
Articles "Published"
Neuroleptic malignant syndrome: Still a risk, but which patients may be in danger?
Treating persistent catatonia when benzodiazepines fail
When clozapine is not an option
Serotonin syndrome
Three case reports of neuroleptic malignant syndrome
"Published" articles for
Promising New Investigators
Neuroleptic malignant syndrome: Answers to 6 tough questions
Neuroleptic malignant syndrome: Don’t let your guard down yet
Depression, medication, and ‘bad blood’
Tips to manage and prevent discontinuation syndromes
What makes aripiprazole the 'different' antipsychotic
Beware ictal activity
Books
Catatonia: From Psychopathology to Neurobiology
Catatonia, An anthology of classical contributions
Neuroleptic malignant syndrome and related disorders
NMS Hotline
Description
Hotline Consultants
Donate Now
Contributions/Membership
Order Form
Home
|
Contact Us
|
Email
:
info@nmsis.org
|
Site Index
Hotline: (888) 667-8367 | Outside of the US: 315-464-4001
© 1996 - 2008 Neuroleptic Malignant Syndrome
Supported by the Malignant Hyperthermia Association of the United States